SS Innovations Appoints Veteran MedTech CFO Sarah Romano

SS Innovations International (NASDAQ: SSII) has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. Romano brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised over $100 million during her career. Her appointment comes as SS Innovations continues pursuing U.S. FDA clearance for its SSi Mantra surgical robotic system while expanding internationally. The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (“SSICRS”) cardiac robotic surgery training program, which welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment.

Romano joins SS Innovations from Vicarious Surgical, another robotic surgery developer, where she oversaw financial initiatives to reduce cash burn and strengthen the balance sheet. Her expertise in capital markets and public-company finance is expected to bolster SS Innovations’ financial strategy as it advances regulatory initiatives and expands its global footprint. The company’s SSi Mantra system is a key focus, with preparations underway for FDA review. The link to the full announcement provides further details on the company’s progress.

The appointment highlights SS Innovations’ commitment to strong leadership as it scales operations. With a growing training program and a robust pipeline, the company is positioning itself as a significant player in the surgical robotics space. Romano’s track record in raising capital and managing public-company finances will be critical as SS Innovations navigates regulatory hurdles and seeks to expand its market presence worldwide.